Tremfya 100 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F5RAV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,380
Award facts
- Contract value 100% obligated
- $48,380.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $48.4K delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 22, 2026, for the supply of Tremfya 100 mg/mL syringes with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Tremfya is a biologic immunosuppressant medication used to treat plaque psoriasis and psoriatic arthritis, indicating this procurement supports the military healthcare system's pharmaceutical supply needs.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.9M through December 31, 2031. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a vast range of pharmaceutical products, specialty medications, generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its established capability to meet federal procurement requirements for critical medical commodities across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26F5RAV?
SPE2DR26F5RAV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F5RAV worth?
The government has obligated $48,380 on SPE2DR26F5RAV.
Is contract SPE2DR26F5RAV an order under another contract?
Yes. SPE2DR26F5RAV is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RAV competed?
The extent of competition for SPE2DR26F5RAV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award